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Abstract
Both CCL20 and human β-defensin 2 (hBD2) interact with the same membrane receptor and
display chemotactic and antimicrobial activities. They are produced by airway epithelia in
response to infectious agents and proinflammatory cytokines. Whereas Brucella spp. can
infect humans through inhalation, their ability to induce CCL20 and hBD2 in lung cells is
unknown. Here we show that B. abortus induces CCL20 expression in human alveolar
(A549) or bronchial (Calu-6) epithelial cell lines, primary alveolar epithelial cells, primary
humanmonocytes, monocyte-derived macrophages and the monocytic cell line THP-1.
CCL20 expression was mainly mediated by JNK1/2 and NF-kB in both Calu-6 and THP-1
cells. CCL20 secretion was markedly induced in A549, Calu-6 and THP-1 cells by heat-killed
B. abortus or a model Brucella lipoprotein (L-Omp19) but not by the B. abortus lipopolysac-
charide (LPS). Accordingly, CCL20 production by B. abortus-infected cells was strongly
TLR2-dependent. Whereas hBD2 expression was not induced by B. abortus infection, it was
significantly induced in A549 cells by conditioned media from B. abortus-infected THP-1
monocytes (CMB). A similar inducing effect was observed on CCL20 secretion. Experiments
using blocking agents revealed that IL-1β, but not TNF-α, was involved in the induction of
hBD2 and CCL20 secretion by CMB. In the in vitro antimicrobial assay, the lethal dose (LD)
50 of CCL20 for B. abortus (>50 μg/ml) was markedly higher than that against E. coli (1.5 μg/
ml) or a B. abortusmutant lacking the O polysaccharide in its LPS (8.7 ug/ml). hBD2 did not
kill any of the B. abortus strains at the tested concentrations. These results show that human
lung epithelial cells secrete CCL20 and hBD2 in response to B. abortus and/or to cytokines
produced by infected monocytes. Whereas these molecules do not seem to exert antimicro-
bial activity against this pathogen, they could recruit immune cells to the infection site.
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Introduction
Airways epithelial cells and alveolar macrophages are the first cells contacted by inhaled micro-
organisms and are therefore prepared to mount rapid immune responses. Besides constituting
an anatomical barrier for microbial invasion, the respiratory epithelium responds to the pres-
ence of pathogens with an inflammatory response, including cytokines and chemokines, aimed
at controlling the infection [1, 2]. Such epithelial response may be further enhanced by the
stimulating action of cytokines secreted by alveolar macrophages [3–5].
Factors produced by the respiratory epithelium in response to infections include beta-defen-
sins, small antimicrobial peptides that can be found in the fluid lining the respiratory tract
together with other antimicrobial components such as lysozyme and cathelicidins. Human
beta-defensin 2 (hBD2) is the most highly expressed beta-defensin in the lung and its expres-
sion is up-regulated during infections or inflammation [6]. All defensins are small cationic,
microbicidal peptides that contain six highly conserved cysteine residues which form three
pairs of intramolecular disulfide bonds. It is postulated that these peptides are attracted by elec-
trostatic forces to the negative charges on the membrane surface provided by lipopolysaccar-
ides (LPS) in Gram-negative bacteria and by several components in Gram-positive bacteria.
Then, they would interact with the lipid bilayer of the bacterial cytoplasmic membrane leading
to alteration of the membrane structure and creation of a physical hole that causes cellular con-
tents to leak out [7]. In particular, hBD2 has been shown to be effective in vitro against several
pathogens, including E. coli, P. aeruginosa, Klebsiella pneumoniae, etc. [8].
The respiratory epithelium also responds to infections with the production of several che-
mokines, including CCL20. Alternatively named liver and activation-regulated chemokine
(LARC), macrophage inflammatory protein-3 (MIP-3) or Exodus-1, CCL20 is a chemoattrac-
tant for immature dendritic cells, effector/ memory T-cells and B-cells. CCL20 and its specific
receptor CCR6 have been shown to mediate in vivo the recruitment of dendritic cells and lym-
phocytes in several tissues, including the lung [9–11]. Of note, the repertoire of CCR6+ T cells
recruited by CCL20 also includes Th17 cells [12], a fact that may be relevant for immune
responses to infectious agents.
Notably, CCL20 and β-defensins, especially hBD2, have been found to share many similari-
ties. Both factors have been shown to interact with the same membrane receptor, CCR6. While
binding of CCL20 to this receptor was known to mediate the chemotactic responses of imma-
ture dendritic cells to this chemokine, more recent studies showed that β-defensins also display
chemotactic activity by binding to CCR6 [13–16]. They can act as chemoattractants for several
cells of the innate and adaptive immunity and can stimulate different immune responses
(including cytokine secretion, dendritic cell maturation, etc.) [17–19]. In particular, hBD2 has
been shown to induce the chemotaxis of memory T cells, immature dendritic cells, mast cells
and neutrophils [15, 20, 21]. On the other hand, whereas CCL20 was initially described as a
chemokine, more recent studies have revealed that this molecule can also display antimicrobial
activities against Gram positive and Gram negative bacteria [22–24]. It has been postulated
that the antimicrobial activity of CCL20 may be due to the fact that this chemokine shares
structural properties with β–defensins, including antiparallel β–pleated sheet core structure
and charge distribution [22].
The expression and/or production of CCL20 and hBD2 have been shown to increase in pul-
monary epithelial cells in response to different infectious agents or antigens [25–31] and also
in response to proinflammatory cytokines [22, 32–37].
Human brucellosis, mainly caused by Brucella melitensis, B. suis or B. abortus, is a world-
wide distributed zoonotic disease which affects over 500,000 people annually [38, 39]. Due to
the easy aerosolization of these bacteria, inhalation of infected aerosols is frequently involved
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in contagion. For this reason Brucella spp. are considered potential biological weapons [39]
and have been classified by CDC and NIAID as category B bioterrorism agents. Airborne trans-
mission has been implicated in outbreaks of human brucellosis in different settings [40, 41]
and also in most cases of laboratory-acquired brucellosis [42, 43]. Despite the importance of
the respiratory route for Brucella entry to the organism, the interaction of these bacteria with
the pulmonary cells has been scarcely studied. We have previously shown that Brucella species
can infect and replicate within human lung epithelial cells, and can induce them to produce the
monocyte chemoattractant MCP-1 [44, 45].
Because of their chemotactic and antimicrobial activities, both CCL20 and beta-defensins
are postulated to have important roles in the pulmonary innate immune response to inhaled
pathogens [46–48], and several studies have shown the induction of CCL20 or hBD2 in lung
tissues during infection. However, nothing is known about the expression of these molecules in
Brucella-infected lung epithelial cells or about their antimicrobial activity against this patho-
gen. The purpose of the present study was to address these issues.
Material and Methods
Reagents
CCL20, hBD2 and hBD3 used in this study were recombinant proteins purchased from Pepro-
Tech (Rocky Hill, NJ). Lipopolysaccharide (LPS) from Brucella abortus 2308 was provided by
Ignacio Moriyón (University of Navarra, Pamplona, Spain). The purity and the characteristics
of this preparation have been published elsewhere [49]. The synthetic bacterial lipohexapeptide
Pam3CSK4 was obtained from InvivoGen (San Diego, USA). Flagellin from Salmonella enter-
ica serovar Typhimurium was provided by Martín Rumbo (Universidad de la Plata, Buenos
Aires. Argentina). LPS from Escherichia coli O55:B5 was provided by Sigma (Taufkirchen, Ger-
many). The lipidated 19 kDa outer membrane protein from B. abortus (L-Omp19) was
obtained in recombinant form in E. coli as described previously [50]. Briefly, the open reading
frame of Omp19 was cloned in the pET22b+ vector, and the resulting plasmid (pET-L-Omp19)
containing the Omp19 gene with a COOH-terminal 6X histidine tag was used to transform
competent E. coli BL21(DE3) bacteria. After induction with isopropyl β-D-thiogalactopyrano-
side, recombinant L-Omp19 was isolated from bacterial membranes by sonication and selective
extraction with Triton X-114, and was further purified by affinity chromatography with a Ni-
NTA resin. After adsorption with Sepharose-polymyxin B the recombinant protein contained
less than 0.25 endotoxin U per μg of protein as assessed by Limulus Amebocyte Lysate Test
(Associates of Cape Cod, East Falmouth, MA).
Bacterial Strains and Growth Conditions
B. abortus 2308 and B. abortus RB51 (rough vaccine strain) were grown overnight in tryptic
soy broth (TSB), harvested by centrifugation, and washed twice in phosphate-buffered saline
(PBS). Bacterial numbers in cultures were estimated by comparing the OD at 600 nm with a
standard curve, but the actual concentration of inocula was checked by plating on tryptic soy
agar plates (TSA). To prepare heat-killed B. abortus (HKBA), bacteria were washed in sterile
PBS, heat killed at 70°C for 30 min, aliquoted, and stored at -70°C until used. All live Brucella
manipulations were performed in biosafety level 3 facilities.
Cell Lines
The A549 cell line (human type II alveolar epithelial) and the human bronchial epithelial cell
line Calu-6 were from the American Type Culture Collection (ATCC). A549 cells were grown
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in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 2 mM L-glutamine, 10%
heat-inactivated FBS (Gibco, USA), 100 U/ml penicillin, 100 mg/ml streptomycin (supple-
mented DMEM). Calu-6 cells were grown in supplemented RPMI 1640 (Gibco). For infection
assays, all epithelial cell lines were seeded at 2 x 105 cells/well in 24 well plates and cultured in a
5% CO2 atmosphere at 37°C for 24 h in antibiotic-free culture medium.
Human Lung Tissue Explants and Bacterial Infection
Pulmonary tissue samples of approximately 1 cm3 were obtained from healthy portions of
human lungs resected during lung transplant. Tissue samples were kindly provided by Favaloro
Hospital in Buenos Aires thanks to a Cooperation Agreement established with the authors’
institution (CONICET). Favaloro Hospital is the reference centre for lung and heart transplant
in Argentina (www.fundacionfavaloro.org). The use of lung tissue samples was approved by
the Institutional Review Boards of Favaloro Hospital (Departamento de Docencia e Investiga-
ción) and CONICET (Dirección de Vinculación Tecnológica) (study protocol N° 3099). As
stated in the Agreement, written informed consent from patients was obtained by the surgeons.
Samples were cultured in RPMI 1640 medium (Sigma) at 37°C and 5% CO2 and incubated
with 500 μl B. abortus 2308 suspensions (107 CFU/ml) or medium for 24 h.
Isolation of Primary Cells from Lung Tissue
Type II alveolar epithelial cells (ATII cells) were isolated from lung tissue obtained as described
above, following published procedures [51]. Briefly, the tissue was rinsed with Solution A
(0.130 M NaCl, 5.2 mM KCl, 10.6 mMHepes, 2.6 mMNa2HPO4, 10 mM D-glucose with pH
adjusted to 7.4) to remove excess blood and debris. It was then perfused repeatedly with Solu-
tion A, using a syringe, until the perfusate was virtually free from leukocytes (104 cell/ml per-
fusate). Lung tissue was minced into pieces of< 0.5 mm thickness. The tissue was digested
with trypsin (0.5% in solution A plus 1.9 mM CaCl2 and 1.29 mMMgSO4) and incubated at
37°C for 20 min in a shaking water bath. The digest was filtrated through a 100 μmmesh and
the filtrate was collected over fetal calf serum containing DNase (DNase I, Sigma; 400 U/ml).
This suspension was filtered through a 40 μmmesh. The filtrate, containing single cells, was
centrifuged and the type II cell–enriched pellet suspended in DMEM/SAGM containing 350
U/ml DNase, then plated into a large flask to allow adhesion of contaminating leukocytes and
other cells. After 2 h, the non-adherent ATII cells were isolated from the medium supernatant
by virtue of their buoyant density over a Percoll discontinuous gradient (1.089 g/l and 1.04 g/l;
Sigma). The interfacial layer enriched in ATII cells was collected and washed twice with Solu-
tion A. Cells were stained with trypan blue and counted in a Neubauer chamber. For further
experiments, a total of 2×105 ATII cells/well were seeded in SAGMmedium (Lonza, Wupper-
tal, Germany) onto 48 well plates coated with type I collagen. Cells were allowed to adhere for
at least 36 h, then nonadherent cells were removed and media was changed every 24 h until
confluence (4–5 d).
Cellular Infections
Brucella infections of respiratory epithelial cells were performed at different multiplicities of
infection (MOI). After dispensing the bacterial suspension the plates were incubated for 2
hours at 37°C under 5% CO2 atmosphere. At the end of the incubation time (time 0 p.i.), each
well was washed three times with sterile PBS. To kill extracellular bacteria, the infected mono-
layers were incubated with 100 μg/ml of gentamicin (Sigma) and 50 ug/ml of streptomycin
(Sigma). At different times after antibiotics addition culture supernatants were harvested to
measure antimicrobial peptides by ELISA.
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In experiments aimed at evaluating the role of TLR2 in cellular responses to infection, THP-
1 and Calu-6 (0.5 x 106 and 2.5 x 105 cells/ml respectively) were incubated with 20 μg/ml of
anti-human TLR2 (clone TL2.1; eBioscience, San Diego, CA) or an isotype-matched control
for 30 min at 37°C before infection with B. abortus 2308. After this, culture supernatants were
harvested as indicated above.
Analysis of Antimicrobial Peptide Production in Response to Antigens
Respiratory epithelial cells (5 x 105 cells/ml) cultured in 24-well plates were stimulated with dif-
ferent B. abortus antigens (HKBA, LPS, L-Omp19) or with TLR agonists (E. coli LPS,
Pam3CSK4). Cultures were incubated for 24 h. At the end of the culture, supernatants were
harvested, aliquoted and stored at -70°C until they were analyzed for antimicrobial peptides.
Stimulation with Conditioned Media
THP-1 monocytes were infected with B. abortus 2308 at an MOI of 100 for 2 h, and then
washed with sterile PBS to remove extracellular bacteria. Conditioned media from infected
monocytes (CMB) were harvested at 24 h p.i., sterilized by filtration through 0.22 μm nitrocel-
lulose filters, and used to stimulate epithelial cells. Conditioned media from uninfected human
monocytes (CMC) cultured for 24 h served as negative controls. For stimulation, conditioned
media were used diluted 1/2, 1/5, or 1/10 in complete medium. At 24 h of stimulation, the
supernatants from stimulated cultures were harvested to measure antimicrobial peptides. To
calculate the specific secretion of each antimicrobial peptide, levels already present in the trans-
ferred conditioned media were subtracted from levels measured after stimulation. Neutraliza-
tion experiments were performed with the IL-1 receptor antagonist (IL-1Ra, provided by R&D
Systems, Minneapolis, MN) or an anti-TNF-α neutralizing antibody (BD Biosciences, San
Diego, CA). Epithelial cells were preincubated for 1 h with IL-1Ra before the addition of condi-
tioned media, or the CMB was preincubated with anti-TNF-α neutralizing antibody for 1 h
before being added to epithelial cells.
Semiquantitative Reverse Transcriptase/Polymerase Chain Reaction
Transcription levels of mRNA for hBD2 were determined by semiquantitative RT-PCR using
previously described primers [52]. Epithelial cells were washed twice with phosphate-buffered
saline and total RNA was isolated using the TRIzol reagent (Invitrogen, Life Technologies).
Total RNA (2 μg) was reverse transcribed using standard reagents (Invitrogen). The comple-
mentary DNA (cDNA) corresponding to 200 ng RNA was amplified in a polymerase chain
reaction (PCR) containing 0.1 mM of hBD-2 specific intron spanning primers (forward primer:
5´-CCAGCCATCAGCCATGAGGGT-3´; reverse primer: 5´-GGAGGCCTTTCTGAATCCGCA-
3´, product: 255 bp) with an internal control for equal amounts of cDNA of a glyceraldehyde-
3-phosphate dehydrogenase (GAPDH)–specific intron spanning primer pair (5´-CCAGCCGA
GCCACATCGCTC-3´; 5´-ATGAGCCCCAGCCTTCTCCAT-3´), which yielded a 360- bp
amplified product. Amplification was performed using 25 to 40 cycles with denaturation at
94°C for 30s, primer annealing at 60°C for 30s, and extension at 72°C for 1 min. PCR products
were subjected to electrophoresis on a 2% agarose gel and visualized by SYBR Safe staining
(Invitrogen). Specificity of hBD-2 encoding PCR products was verified by sequencing.
Measurement of Antimicrobial Peptides
Human CCL20 and hBD2 were measured in culture supernatants of cells or lung tissue
explants infected with Brucella or stimulated with Brucella antigens by sandwich ELISA (R&D,
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Minneapolis or Peprotech respectively) using paired cytokine-specific mAbs, according to the
manufacturer’s instructions.
Signaling Pathways in CCL20 Production
To examine the signaling pathways involved in CCL20 secretion, THP-1 and Calu-6 cells were
pretreated with SB203580 (p38 MAPK inhibitor), PD98059 (Erk1/2 MAPK inhibitor),
SP600125 (Jnk1/2 inhibitor) BAY 11-7082 (NF-κB inhibitor) or vehicle (dimethyl sulfoxide,
DMSO). The inhibitors were added one hour before infection with B. abortus and were kept
throughout the experiment (24 h). Cell viability after incubation with these inhibitors was
higher than 90%, as assessed by staining with trypan blue. To account for any possible effect of
DMSO on cell viability, cell cultures not treated with the inhibitors were treated with the high-
est final concentration of DMSO used in these studies (0.01%), and the results were compared
with those of cell cultures not exposed to DMSO.
Antimicrobial Assay
A standard colony-forming assay (CFA) was used [23], with slight modifications. Briefly,
approximately 104 CFU log phase microorganisms were mixed with CCL20, hBD2 or hBD3 at
different final concentrations (0.1 to 50 μg/ml) in 0.1 ml of 10 mM potassium phosphate buffer
(pH 7.4) containing 1% TSB. For the antibacterial assay, the mixture was incubated for 2 h at
37°C in shaking incubator (250 rpm). After serial dilution with 10 mM potassium phosphate
buffer (pH 7.4) containing 1% TSB, the diluted mixture was plated in triplicate on TSA. The
plates were incubated for 72 h at 37°C, and the colonies formed were counted.
Results
B. abortus Strain Induces CCL20 but Not hBD2 Secretion in Airway
Epithelial Cells and Macrophages
As airway epithelial cells have been shown to increase the expression of hBD2 and/or CCL20 in
response to infection with several pathogens [28, 29, 34, 53, 54], we sought to determine
whether infection with virulent B. abortus 2308 also increases the expression of hBD2 and
CCL20 in these cells. Analysis by RT-PCR and ELISA revealed that B. abortus 2308 did not
induce mRNA expression or protein secretion of hBD2 on the alveolar cell line A549 (Fig 1) or
the bronchial cell line Calu-6 (data not shown), although both cell lines were able to express
hBD2 mRNA in response to proinflammatory cytokine IL-1β (positive control).
In contrast, infection with B. abortus increased CCL20 secretion in a MOI dependent man-
ner in both Calu-6 cells and A549 cells, although chemokine levels were much lower in the
later case (Fig 2A, upper and middle panels). CCL20 levels produced by primary cultures of
human alveolar epithelial cells in response to B. abortus infection were similar to those pro-
duced by the Calu-6 bronchial cell line (Fig 2A, bottom panel).
The production of hBD2 and CCL20 in response to B. abortus infection was also evaluated
in cells of the monocyte/macrophage lineage. Infection of the monocytic cell line THP-1 with
B. abortus 2308 at MOI 1:10 and 1:100 did not induce hBD2 mRNA expression at any time
point (data not shown). In contrast, B. abortus infection induced a significant increase of
CCL20 secretion by THP-1 cells in a MOI dependent manner (Fig 2B, upper panel). In line
with these results, primary culture blood monocytes and monocyte-derived macrophages pro-
duced significant amounts of CCL20 in response to B. abortus infection (Fig 2B, middle and
bottom panels).
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To further address the physiological relevance of CCL20 secretion by lung cells, the secre-
tion of this chemokine by Brucella-infected human lung tissue explants was also assessed. As
shown in Fig 3, after 24 h of growth in serum- free media, the levels of CCL20 in culture super-
natants of infected explants were significantly higher than those produced by non-infected
control explants (P<0.05).
JNK and NF-κB Signaling Pathways Are Involved in the Secretion of
CCL20 by Brucella Infected Lung Epithelial Cells and Macrophages
MAPK and NF-κB signaling pathways have been shown to be involved in the CCL20 response
to infections or stimulation with microbial antigens, but the contribution of each pathway var-
ies according to the cell type and/or the pathogen considered [30, 55]. To determine the poten-
tial role of p38, JNK1/2, ERK1/2, and NF-κB signaling pathways in CCL20 production by lung
epithelial cells and macrophages in response to B. abortus infection, inhibition experiments
were performed with the specific inhibitors SB203580, SP600125, PD98059 and BAY 11-7082,
respectively. The production of CCL20 was strongly reduced (P< 0.001 as compared to
untreated infected cells) by the JNK1/2 inhibitor and the NF-κB inhibitor in both Calu-6 and
THP-1 cells, so that CCL20 levels produced by infected cells pretreated with these inhibitors
Fig 1. Human alveolar epithelial cells do not produce hBD2 in response toB. abortus infection. A549
cells were infected with B. abortus at different multiplicities of infection (MOI). At 48 h p.i. transcription levels
of mRNA for hBD2 were determined by semiquantitative RT-PCR (upper panel), and culture supernatants
were harvested for hBD2 determination by commercial ELISA (lower panel). As a positive control of hBD2
induction, cells were stimulated in parallel with recombinant IL-1β. ELISA results are the mean ± SEM of three
independent experiments. **, p<0.01 and ns, non-significant difference versus untreated (control) cells
(ANOVA followed by Dunnett’s test).
doi:10.1371/journal.pone.0140408.g001
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Fig 2. B. abortus induces CCL20 secretion by airways epithelial cells and humanmonocytes. (A) Calu-6 and A549 cell lines and primary alveolar
epithelial cells were infected with B. abortus at MOIs 50 to 1,000 or were exposed to IL-1 β (1ng/ml) or media alone. (B) THP-1 cells, human peripheral blood-
derived monocytes and monocyte derived-macrophages were infected with B. abortus at MOIs 10 to 100 or left untreated. Cell culture supernatants were
harvested at 48 h, and CCL20 levels were measured by ELISA. Results are the mean ± SEM of three independent experiments. *, p<0.05; **, p<0.01; ***,
p<0.001; and ns, non-significant difference versus non-infected cells (NI) (ANOVA followed by Dunnett’s test).
doi:10.1371/journal.pone.0140408.g002
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did not differ significantly from those produced by uninfected controls (Fig 4). Conversely,
inhibition of p38 and ERK1/2 had no effect on CCL20 secretion by Brucella infected-THP-1
monocytes but produced a partial inhibition in Brucella-infected Calu-6 cells. These results
suggest that JNK1/2 and NF-κB pathways are involved in CCL20 responses to B. abortus infec-
tion in both cell types, whereas p38 and ERK1/2 pathways may also have a role in the response
of Calu-6 cells.
B. abortus-Induced Secretion of CCL20 Is Mediated by L-Omp19, but
Not by B. abortus LPS
To test whether B. abortus viability is necessary to induce CCL20 production by lung epithelial
cells and macrophages, the ability of heat-killed B. abortus (HKBA) to induce CCL20 was
examined. As LPS from Escherichia coli is known to induce CCL20 expression in different cell
types, including type II pneumocytes [31, 55] it was used as a positive control. The secretion of
Fig 3. B. abortus induces CCL20 secretion in human lung tissue explants. Samples of healthy lung
tissue (approximately 1 cm3) from two donors (Lung 1 and Lung 2, respectively) were incubated with a B.
abortus 2308 suspension (107 CFU/ml) or medium for 24 h. CCL20 levels were determined by ELISA in
culture supernatants from infected (I) and non-infected (NI) explants. Results are the mean ± SEM of triplicate
determinations for each sample. *,P < 0.05 as compared with the non-infected explant from the same donor
(Student t test).
doi:10.1371/journal.pone.0140408.g003
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CCL20 was markedly enhanced in culture supernatants from A549, Calu-6 and THP-1 cells
stimulated with HKBA when compared with unstimulated cells (Fig 5). For all cell lines a sig-
nificant (P< 0.01) CCL20 secretion was detected in cultures stimulated with 1×109 bacteria/
ml. These results suggest that the secretion of CCL20 can be induced by a structural component
of B. abortus. As it has been seen demonstrated that B. abortus lipoproteins induce cytokine
production in different cells types [50, 56], we hypothesized that lipoproteins could also
Fig 4. Role of MAPK pathways and NF-κB in CCL20 secretion by Brucella- infected lung epithelial
cells andmonocytes. Calu-6 and THP-1 cells were incubated with inhibitors of MAPK pathways (PD:
inhibitor of Erk1/2; SB: inhibitor of p38 and SP: inhibitor of Jnk1/2) or NF-κB pathways (BAY) 1 h before the
beginning of infection and kept throughout. Culture supernatants were harvested at 24 h post infection. NI:
non-infected cells. Data are mean ± SEM of four independent experiments. Asterisks above bars indicate
statistically significant differences (***, p < 0.001) relative to NI (ANOVA followed by Tukey’s Multiple
Comparison test).
doi:10.1371/journal.pone.0140408.g004
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Fig 5. CCL20 production by lung epithelial cells andmonocytes in response to B. abortus antigens
and TLR agonists. Cells were stimulated for 24 h with heat-killed B. abortus (HKBA), the L-Omp19
lipoprotein (OMP, recombinant form obtained in E. coli) or the LPS from B. abortus (LPS Ba), or with the TLR
agonists LPS from Escherichia coli (LPS Ec), and the lipohexapeptide Pam3CSK4 (P3C) (agonists for TLR4
and TLR2 respectively). The concentration of CCL20 in culture supernatants was determined by ELISA. Data
are expressed as mean ± SEM of values from three independent experiments. Asterisks indicate statistical
Lung CCL20 and β-Defensin 2 in Brucella Infection
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mediate CCL20 production. To investigate this hypothesis we used recombinant L-Omp19, a
model Brucella lipoprotein. A549, Calu-6 and THP-1 cells were incubated with L-Omp19
obtained in recombinant form in E. coli, and culture supernatants were harvested 24 hours
later to measure the secretion of CCL20. As shown in Fig 5, L-Omp19 induced a significant
(P< 0.01) secretion of CCL20 in a dose-dependent fashion in all the three cell types under
study. The production of CCL20 was also induced in all cells upon incubation with a synthetic
lipohexapeptide (Pam3SCK4) that mimics the structure of the lipid moiety of bacterial lipopro-
teins. In contrast, B. abortus LPS did not induce CCL20 production even when used at high
doses (5,000 ng/ml). Altogether, these results indicate that B. abortus lipoproteins are involved
in the induction of CCL20 secretion by lung epithelial cells and monocytes in contact with this
bacterium.
TLR2 Recognition Mediates CCL20 Secretion by Brucella-Infected Cells
As our results indicate that Brucella lipoproteins, but not its LPS, induce CCL20 secretion by
lung epithelial cells and monocytes, we hypothesized that TLR2 recognition may be involved in
the signaling network leading to the secretion of this chemokine in B. abortus-infected cells. To
test this hypothesis, THP-1 monocytes and Calu-6 epithelial cells were incubated with a block-
ing anti-TLR2 antibody before infection with live B. abortus 2308 (Fig 6). Blocking of TLR2 sig-
nificantly reduced the CCL20 secretion of the infected cells (67.5% for Calu-6 and 77.9% for
THP-1 cells), while incubation with an isotype control did not modify the CCL20 secretion in
any cell type.
Factors Secreted by B. abortus-Infected Monocytes Enhance the
Secretion of CCL20 and hBD2 by Alveolar Epithelial Cells
It has been shown that airways epithelial cells release CCL20 and HBD2 in response to TNF-α
and IL-1β [34, 57]. In the lung, resident alveolar macrophages and monocytes recruited to the
infectious focus may respond to B. abortus with proinflammatory cytokines that, in turn, could
stimulate the CCL20 and hBD2 production by airways epithelial cells. To test this hypothesis,
A549 cells were stimulated with conditioned media from B. abortus-infected THP-1 monocytes
(CMB) used at different dilutions. After 24 h of stimulation CCL20 and hBD2 were measured
in culture supernatants by ELISA. Other A549 cells were stimulated in parallel with condi-
tioned medium from uninfected monocytes (CMC) at the same dilutions. Levels of CCL20
(2150 ± 60.2 pg/ml) and hBD2 (14.4 ± 1.0 pg/ml) already present in the CMB were subtracted
to determine specific stimulation (levels of both molecules were undetectable in CMC).
Whereas as shown above B. abortus infection did not induce a significant increase of hBD2
secretion in A549 alveolar epithelial cells and induced only low levels of CCL20, CMB stimula-
tion resulted in a significant increment in the levels of both substances in culture supernatants
from A549 cells. Mean levels of CCL20 were 8,377 ± 357.8 pg/ml in cells stimulated with CMB
at 1/2, whereas they reached only 524 ± 50 pg/ml in cells stimulated with CMC and no level
was detected under unstimulated conditions (Fig 7A).
A similar stimulatory effect was observed for hBD2. No mRNA expression was detected in
A549 cells under unstimulated conditions, but CMB stimulation at different dilutions induced
a marked expression of hBD2 mRNA (no induction was observed upon stimulation with
CMC) (Fig 7B). To correlate hBD2 mRNA expression with protein abundance, levels of hBD2
significant differences (*, p < 0.05; **, p < 0.01) as compared to non-stimulated cells (NS). (ANOVA followed
by Dunnett’s Multiple Comparison test).
doi:10.1371/journal.pone.0140408.g005
Lung CCL20 and β-Defensin 2 in Brucella Infection
PLOS ONE | DOI:10.1371/journal.pone.0140408 October 8, 2015 12 / 23
were determined by ELISA in culture supernatants from CMB- or CMC-stimulated A549 cells.
As shown in Fig 7B, the addition of CMC did not stimulate hBD2 secretion as compared to
basal values, whereas CMB added at 1/2, 1/5 or 1/10 dilution increased hBD2 secretion by
81.5 ± 5.5, 66.7 ± 9.4 and 64.5 ± 12.5 pg/ml, respectively. These data indicate that CCL20 and
Fig 6. TLR2 recognition mediates CCL20 secretion by B. abortus-infected bronchial epithelial cells
andmonocytes.Calu-6 and THP-1 cells were preincubated with a neutralizing anti-TLR2 antibody or an
isotype control for 1 h at 37°C before infection with B. abortus. Culture supernatants were harvested at 24 h p.
i. to measure CCL20 by ELISA. Data are mean ± SEM of CCL20 levels measured in three independent
experiments. Asterisks indicate statistical significant differences (*, p < 0.05; ***, p < 0.001) as compared to
non-infected cells (NI) (ANOVA followed by Tukey’s Multiple Comparison test).
doi:10.1371/journal.pone.0140408.g006
Lung CCL20 and β-Defensin 2 in Brucella Infection
PLOS ONE | DOI:10.1371/journal.pone.0140408 October 8, 2015 13 / 23
Fig 7. Factors secreted by B. abortus-infectedmonocytes enhance the secretion of CCL20 and hBD2
by alveolar epithelial cells. (A) Cells were exposed to different dilutions of conditioned medium from B.
abortus-infected THP-1 monocytes (CMB) or from uninfected monocytes (CMC), and 24 h later the levels of
CCL20 were measured in culture supernatants. (B) Cells were treated as above and 24 h later transcription
levels of mRNA for hBD2 were determined by semiquantitative RT-PCR (upper panel), and culture
supernatants were harvested for measuring hBD2 levels by commercial ELISA (lower panel). ELISA data are
mean ± SEM of CCL20 or hBD2 levels measured in three independent experiments in stimulated cultures
after subtracting preexisting levels in the transferred CMB or CMC. **, p<0.01, ***, p<0.001, and ns, non-
significant difference versus non-stimulated (NS) cells (ANOVA followed by Dunnett’s test).
doi:10.1371/journal.pone.0140408.g007
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hBD2 secretion from CMB-stimulated alveolar epithelial cells is much greater than that follow-
ing direct infection of cells with B. abortus.
As both TNF-α and IL-1β are known to induce CCL20 and hBD2 secretion by pulmonary
epithelial cells [34, 57, 58] and are released by B. abortus-infected monocytes and alveolar mac-
rophages [45, 59], they were considered potential candidates for mediators of the effects of
CMB on alveolar epithelial cells. A neutralizing anti-human TNF-α antibody and IL-1Ra, the
naturally occurring competitive inhibitor of IL-1β bioactivity, were used to test this hypothesis.
Pretreatment of CMB with anti-TNF-α antibody did not reduce the CCL20 or hBD2 secretion
of CMB-stimulated A549 cells (data not shown). However, treatment of A549 cells with IL-1Ra
before stimulation with CMB at 1/2 or 1/5 dilution reduced CCL20 secretion by 48.3% and
86.3%, respectively (Fig 8A). Similarly, hBD2 secretion by cells stimulated with CMB at 1/5
was reduced by 63.6% after IL-1Ra treatment, whereas mRNA transcription levels were
reduced to non-detectable (Fig 8B). These results suggest that IL-1β is essential for CCL20 and
hBD2 production by CMB-stimulated A549 cells.
Antimicrobial Activity
CCL20 and hBD2 were tested for antimicrobial activity against B. abortus 2308 using the stan-
dard colony-forming assay after coincubation of 105 CFU bacteria in 0.1 ml 10 mM potassium
phosphate buffer (pH 7.4) with various concentrations of human CCL20 and hBD2. CCL20
killed B. abortus 2308 with a lethal dose (LD) 50 (the dose that achieves 50% reduction of
CFU)> 50 ug/ml (Fig 9). The capacity of CCL20 to kill E. coli 25922 was also examined as a
positive control. CCL20 demonstrated anti-E. coli activity with a LD50 of 1.5 μg/ml. Given the
comparative resistance of B. abortus to CCL20 lysis, we asked whether the presence of O poly-
saccharide in its LPS may exert a protective effect. To test this we evaluated the antimicrobial
activity of CCL20 against B. abortus RB51, a rough vaccine strain devoid of O polysaccharide.
As seen in Fig 9, CCL20 killed B. abortus RB51 in a dose-dependent manner with a LD50 of 8.7
ug/ml, suggesting that the O polysaccharide is involved in the relative resistance of B. abortus
to the antimicrobial effects of CCL20. In parallel experiments, hBD2 and hBD3 (data not
shown) did not kill any of the B. abortus strains at the tested concentrations. Thus, CCL20 is
more potent than β-defensins in terms of killing B. abortus.
Discussion
Antimicrobial peptides are considered an important component of the host defense at mucosal
surfaces, including the lung. Beta-defensins produced by the respiratory epithelial cells and
alveolar macrophages are secreted into the airway surface fluid, where they increase their levels
during lung infectious and inflammatory processes. Besides their direct antimicrobial function,
β-defensins have multiple roles as mediators of inflammation [47, 48, 60]. Similarly, CCL20
has been shown to be produced by lung epithelial cells [22, 30, 31] and to be induced in the
lungs by some infections [30, 31]. Different studies suggest that pulmonary CCL20 could not
only exert chemoattractant activities on lymphocytes and dendritic cells [61] but could also
exert direct antimicrobial effects [22]. Despite the known roles of β-defensins and CCL20 in
the pulmonary defense against infections, and the ability of Brucella spp. to infect hosts
through inhalation, nothing is known about the expression of these molecules in Brucella-
infected lung epithelial cells and their antimicrobial activity against this pathogen.
Here we show that B. abortus induces the expression of CCL20 on human alveolar (A549)
or bronchial (Calu-6) epithelial cell lines, and also in primary alveolar epithelial cells obtained
from human lungs. These findings agree with similar results obtained for airway epithelial cells
infected with other respiratory pathogens [30, 62, 63] or stimulated with microbial antigens
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Fig 8. IL-1βmediates the stimulating effect of CMB on CCL20 and hBD2 secretion by alveolar
epithelial cells. A549 cells were preincubated with IL-1Ra for 1 h at 37°C before stimulation with conditioned
medium from B. abortus-infected THP-1 monocytes (CMB) or from uninfected monocytes (CMC) (at 1/2 and
1/5 dilution in A, at 1/5 dilution in B). At 24 h post-stimulation CCL20 levels (A) and hBD2 levels (B) were
measured in culture supernatants, and the expression of mRNA for hBD2 was determined in cells. ELISA
data are mean ± SEM of CCL20 or hBD2 levels measured in three independent experiments. **, p<0.01,
***, p<0.001, and ns, non-significant difference versus non-stimulated (NS) cells (ANOVA followed by
Dunnett’s test).
doi:10.1371/journal.pone.0140408.g008
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[64, 65]. CCL20 is also produced by monocytes/macrophages in response to infections or
microbial antigens [54, 66]. This may be relevant during pulmonary infections given the pres-
ence of resident alveolar macrophages and the recruitment of monocytes by inflammatory che-
mokines. In particular, previous studies have shown that Brucella-infected airway epithelial
cells produce MCP-1, a chemoattractant for monocytes [45]. In the present study we found
that the monocytic THP-1 cell line as well as primary monocytes and monocyte-derived mac-
rophages respond to B. abortus infection with an enhanced production of CCL20. Moreover,
the same response was observed when human lung tissue explants were infected with B. abor-
tus ex vivo, strongly suggesting that an enhanced CCL20 secretion may take place in the lungs
of infected patients. Collectively, these results suggest that different cell types may respond to a
B. abortus pulmonary infection with the production of CCL20, potentially contributing to the
recruitment of lymphocytes and dendritic cells to the infection site. Of note, the CCL20 levels
produced by epithelial cells, monocytic/macrophagic cells and lung explants in response to B.
abortus infection fit well with levels reported to be chemoattractant for dendritic cells and lym-
phocytes [31, 67–69].
Previous studies have shown a varying contribution of MAPK and NF-κB signaling path-
ways to the CCL20 response to infections or microbial antigens according to the cell type and/
or the pathogen considered. In the present study, CCL20 expression was mainly mediated by
JNK1/2 and NF-κB in both Calu-6 and THP-1 Brucella-infected cells, with a partial contribu-
tion of p38 and ERK1/2 in Calu-6 cells. A previous study demonstrated the involvement of p38
signaling in the CCL20 response of bronchial epithelial cells to Chamydophila pneumoniae
[62], and other study revealed that both p38 and NF-κB are involved in the CCL20 response of
murine lung epithelial cells to Burkholderia pseudomallei [30]. These studies, however, did not
test the potential involvement of ERK1/2 and JNK1/2 pathways. In line with our findings, all
the four signaling pathways have been found to be involved in CCL20 production by gingival
fibroblasts in response to E. coli LPS [55].
Fig 9. Antimicrobial activity of CCL20. B. abortus 2308, B. abortusRB51, and E. coli 25922 were
incubated with various concentrations of recombinant CCL20 for 2 h and CFU were determined by plating
serial dilutions of the mixture on agar. Data shown are means ± SEM of CFU counts from three independent
experiments.
doi:10.1371/journal.pone.0140408.g009
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The induction of CCL20 secretion by B. abortus seems to be independent of bacterial viabil-
ity as it was also markedly induced by heat-killed B. abortus (HKBA) in A549, Calu-6 and
THP-1 cells. These results agree with previous studies showing the induction of different cyto-
kines and chemokines by HKBA in different cell types [50, 56]. Those studies further demon-
strated that the responses induced by HKBA were mediated by B. abortus lipoproteins but not
by its LPS, and that they depended on TLR2 signaling. The results of the present study fully
agree with such reports as we found that CCL20 secretion is elicited by L-Omp19 (a model B.
abortus lipoprotein) but is not elicited by B. abortus LPS. Also in agreement with previous stud-
ies, CCL20 secretion was TLR2-dependent. The inability of B. abortus LPS to induce CCL20
secretion by epithelial and monocytic cells agrees with the reported weak proinflammatory
activity of this molecule, which has been mainly attributed to the unusual composition of its
lipid A [50, 70–72].
In contrast to the results obtained for CCL20, no induction of hBD2 at either the mRNA
level or protein level was detected in human lung epithelial cells or monocytes infected with B.
abortus, although hBD2 mRNA expression increased significantly in response to the proin-
flammatory cytokine IL-1β added as positive control. These results contrast with those found
for infections of lung epithelial cells by other pathogens such asMycobacterium tuberculosis,
Klebsiella pneumoniae, Pseudomonas aeruginosa or Aspergillus fumigatus [27, 28, 34, 73]. The
reasons for the lack of hBD2 induction in A549 cells upon B. abortus infection are intriguing as
A549 was one of the cell lines used in all these previous studies and mRNA induction was
detected in every case. Interestingly, however, in most cases hBD2 induction had particular
requirements. The mRNA expression of this defensin was induced by a non-capsular mutant
of K. pneumoniae but not by its capsular counterpart, and in the case of P. aeruginosa only the
mucoid phenotype had an inducing effect. In the case of A. fumigatus, hBD2 expression was
higher in cells exposed to swollen conidia, compared to resting conidia or hyphal fragments.
Therefore, it seems that the induction of hBD2 in A549 cells and other lung epithelial cells is
highly dependent on the composition of the outer membrane of pathogens. Brucella LPS is
known to have an atypical composition, in particular regarding lipid A backbone and acylation,
probably responsible for its low proinflammatory activity [50, 70–72, 74]. Further studies will
be needed to determine whether the particular composition of B. abortus LPS may be responsi-
ble for the lack of hBD2 response of lung epithelial cells to this pathogen.
To our best knowledge there are no studies comparing in parallel the production of hBD2
and CCL20 by lung epithelial cells in response to microbes or microbial antigens. In colonic
epithelial cells (Caco-2) both molecules were induced (at the mRNA level) by wild type entero-
pathogenic E. coli, but only CCL20 was induced by a mutant lacking flagellin [75]. This sug-
gests that, at least in this model, the induction pathways leading to CCL20 expression differed
from those involved in hBD2 expression.
While lung epithelial cells did not produce hBD2 in response to B. abortus infection, it
must be kept in mind that in the context of pulmonary infections interactions between these
cells and resident or recruited phagocytes may amplify the innate immune response to patho-
gens. To model this type of interactions we stimulated lung epithelial cells with conditioned
medium from B. abortus-infected monocytes (CMB). Notably, we found that hBD2 expres-
sion was significantly induced in A549 cells by CMB, and a similar inducing effect was
observed on CCL20 secretion. Experiments using blocking agents revealed that IL-1β, but not
TNF-α, was involved in the induction of hBD2 and CCL20 secretion by CMB. These findings
resemble those previously reported by us for chemokine responses of A549 cells and human
bronchial epithelial cells to B. abortus infection [45]. In that previous study, lung epithelial
cells had a null or poor proinflammatory response to direct B. abortus infection but exhibited
a marked increase of chemokine production (IL-8 and MCP-1) upon stimulation with CMB.
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IL-1β was shown to mediate these inductions in A549 cells and TNF-α in bronchial epithelial
cells. In line with these previous findings, in the present study IL-1β was shown to mediate
CCL20 and hBD2 induction by CMB in A549 cells. These results also agree with previous
reports showing that IL-1β induces CCL20 and hBD2 secretion by pulmonary epithelial cells
[34, 57, 58]. Whereas in these studies TNF-α also induced the production of these molecules,
such effect was not noted in the present study. It must be noted, however, that in two previous
studies [34, 57] stimulation was performed with recombinant TNF-α and not with condi-
tioned medium. In the other study, in which A549 cells were stimulated with conditioned
medium from LPS-stimulated monocytes, IL-1β was a more potent inducer of hBD2 than
TNF-α [58].
Beside their immunomodulatory functions, both hBD2 and CCL20 have been shown to
have direct antimicrobial activity against certain Gram-positive and Gram-negative bacteria
[23, 34]. However, the antimicrobial activity of these molecules against B. abortus has never
been tested. In the present study we found that CCL20 killed B. abortus in vitro with a lethal
dose (LD) 50 higher than 50 μg/ml, which was much higher than the LD50 dose against E. coli
(1.5 μg/ml). The LD50 dose for B. abortus was also higher than those reported for several bacte-
ria, including Pseudomonas aeruginosa,Moraxella catarrhalis, Enterococcus faecium, Staphylo-
coccus aureus or Streptococcus pyogenes, which ranged from 0.2 to 10 μg/ml [23]. Therefore, B.
abortus seems to be comparatively resistant to the antimicrobial action of CCL20. Moreover,
the LD50 dose of CCL20 for B. abortus was much higher than the levels of this chemokine pro-
duced by lung epithelial cells infected with B. abortus or stimulated with CMB. Overall, these
results suggest that whereas CCL20 may have chemotactic and immunomodulatory roles dur-
ing pulmonary B. abortus infections, it would not have an antimicrobial role against this
pathogen.
As lung epithelial cells stimulated with CMB produced hBD2, it was of interest to test a
potential antimicrobial action of this defensin against B. abortus. While the LD50 for P. aerugi-
nosa and E. coli have been reported to be around 5 μg/ml [34], B. abortus resisted hBD2 (and
hBD3) doses of up to 50 μg/ml. As mentioned, there are no previous studies on the antimicro-
bial activity of β-defensins against Brucellamicroorganisms. However, it has been shown that
Brucella is resistant to antimicrobial peptides from other families, such as polymixn B, melittin
(honey bee), magainin (frog skin) and cecropin (pig) [76]. The results of the present study
allow expanding the list of antimicrobial peptides that lack bactericidal activity against B.
abortus.
The resistance of smooth strains of Brucella to these antimicrobial peptides has been attrib-
uted in part to the O polysaccharide in the LPS of these bacteria, as smooth strains (expressing
the polysaccharide) are more resistant to cationic peptides (polymyxin B, melittin, cecropin
and others) than rough strains (devoid of the polysaccharide) [77]. In the present study, how-
ever, a B. abortusmutant devoid of O polysaccharide (RB51) was no more sensitive than its
smooth counterpart to hBD2 concentrations up to 50 μg/ml. In contrast, the lack of O poly-
saccharide seemed to affect the sensitivity of B. abortus to CCL20 as the LD50 against this
mutant was of 8.7 ug/ml, which is significantly lower than the LD50 against wild type B.
abortus.
Collectively, the results of the present study show that human lung epithelial cells secrete
CCL20 and hBD2 in response to B. abortus and/or to cytokines produced by infected mono-
cytes. Whereas these molecules are produced at concentrations that do not seem to exert anti-
microbial activity against this pathogen, they could be involved in immunomodulatory
functions during pulmonary Brucella infections, such as the recruitment and activation of
immune cells.
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